Transplantatsiya gemopoeticheskikh stvolovykh kletok i gennaya terapiya v lechenii patsientov, infitsirovannykh VICh

References

[1] Liu R., Paxton W.A., Choe S. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.

[2] Ayash L.J., Ratanatharathorn V., Braun T. et al. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia. Am. J. Hematol. 2007; 82: 6-14.

[3] Huzicka I. Could bone marrow transplantation cure AIDS? Med. Hypotheses 1999; 52: 247-57.

[4] Taylor B.S., Sobieszczyk M.E., McCutchan F.E., Hammer S.M. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 2008; 358: 1590-602.

[5] Schmid C, Weisser M., Ledderose G. et al. Dosereduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results. Dtsch. Med. Wochenschr. 2002; 127: 2186-92.

[6] Skrabal K., Low A.J., Dong W. et al. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model. J. Clin. Microbiol. 2007; 45: 279-84.

[7] Fanning G., Amado R., Symonds G. Gene therapy for HIV/AIDS: the potential for a new therapeutic regimen. J. Gene Med. 2003; 5: 645-53.

[8] Macpherson J.L., Ely J.A., Sun L.Q., Symonds G.P. Ribozymes in gene therapy of HIV-1. Front. Biosci. 1999; 4: D497-D505.

[9] Sun L.Q., Wang L., Gerlach W.L., Symonds G. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res. 1995; 23: 2909-13.

[10] Wang L., Witherington C, King A. et al. Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum. Gene Ther. 1998; 9: 1283-91.

[11] Macpherson J.L., Boyd M.P., Arndt A.J. et al. Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T lymphocytes in HIV-infected patients. J. Gene Med. 2005; 7: 552-64.

[12] Amado R.G., Mitsuyasu R.T., Rosenblatt J.D. et al. Anti-human immunodeficiency virus hematopoietic progenitor celldelivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 2004; 15, 251-62.

RIGHTS & PERMISSIONS

Eco-Vector